Sequoia Capital is a prominent venture capital firm founded in 1972 and based in Menlo Park, California. The firm specializes in investing across various stages of startups, including seed, early, and growth stages, and focuses on sectors such as technology, healthcare, financial services, internet, and mobile. Sequoia typically invests between $100,000 and $1 million in seed companies, $1 million to $10 million in early-stage ventures, and $10 million to $100 million in growth investments. The firm operates globally, with significant activities in regions like Israel, China, and India, where it partners with dynamic founders to build successful companies. Sequoia's extensive portfolio includes notable firms and offers valuable insights and resources, benefiting from decades of experience in the venture capital landscape.

Flare Capital Partners is a Boston-based venture capital firm established in 2013, specializing in early-stage and growth equity investments in healthcare technology. The firm focuses on areas such as medical devices, biopharmaceuticals, diagnostics, and digital health technologies, emphasizing transformational solutions that enhance value-based healthcare. Flare Capital Partners is known for its strategic resources and commitment to entrepreneurial success, having raised significant funds dedicated to healthcare innovation. The firm has a diverse portfolio that includes investments in companies like Aetion, Bright Health, and Iora Health. With a keen interest in leveraging mobile solutions and big data analytics, Flare Capital aims to support advancements in healthcare that improve patient outcomes and operational efficiency.

Enhanced Capital Partners, founded in 1999 and headquartered in New York, is a national investment firm that specializes in equity and debt investments in small and mid-sized companies across the United States. With over $400 million under management, the firm employs a flexible investment strategy aimed at promoting the growth and expansion of businesses. Enhanced Capital focuses on various sectors, including healthcare technology and technology, media, and telecommunications. As a subsidiary of P10 Holdings, it seeks to maximize the growth potential of companies poised for rapid development through its practical investment approach.

General Catalyst Group Management, LLC is a private equity and venture capital firm founded in 2000 and based in Cambridge, Massachusetts, with additional offices in North America and Europe. The firm specializes in early-stage and growth equity investments, focusing on a diverse range of sectors including technology, advanced materials, clean energy, cybersecurity, healthcare, and consumer services. General Catalyst seeks to invest in companies that demonstrate strong growth potential, typically targeting those with an EBITDA between $3 million and $30 million and minimum revenues of $10 million. The firm has managed eight venture capital funds with approximately $3.75 billion in capital commitments. It emphasizes building lasting relationships with entrepreneurs and provides mentorship to foster success, enabling companies to scale effectively. General Catalyst primarily invests in North America and Australia, with a preference for seed investments in Silicon Valley, New York, and Boston.

Aier Eye Hospital Group Co., Ltd. is a prominent ophthalmology hospital group based in Changsha, China, founded in 2003. The organization operates approximately 200 ophthalmic hospitals in mainland China, along with facilities in Europe, the United States, and Hong Kong. Aier Eye specializes in a wide range of eye care services, including diagnosis and treatment of fundus diseases, myopia, cataracts, glaucoma, and pediatric ophthalmology. Additionally, the group offers surgical services, optometry, and aesthetic eye shaping treatments. Aier Eye is committed to providing high-standard medical care and also conducts training courses focused on cataract prevention and treatment. Through its extensive network and expertise, Aier Eye Hospital Group aims to enhance eye health and improve patient outcomes across its various locations.

Qiming Venture Partners is a prominent venture capital firm established in 2006 and headquartered in Shanghai, with additional offices in Beijing, Suzhou, and Hong Kong. The firm specializes in investing in early to growth-stage companies across various sectors, including media and internet, information technology, consumer and retail, healthcare, and clean technology in China. Since its inception, Qiming has built a reputation as a leading investment firm in the region, managing multiple funds with over $1 billion in assets. The firm aims to support promising entrepreneurs and innovative businesses, contributing to the development of China's dynamic economic landscape.

Techstars Central LLC, founded in 2006 and based in Boulder, Colorado, operates as a startup accelerator and venture capital firm focused on supporting early-stage technology-oriented companies. It specializes in a mentorship-driven accelerator program, selecting ten startups each summer to participate in a three-month incubation period, offering funding of $120,000 in exchange for equity. Techstars invests primarily in sectors such as fintech, artificial intelligence, blockchain, augmented reality, and IoT, while avoiding investments in medical devices, healthcare technology, and local service-oriented businesses. In addition to its primary accelerator, Techstars has various specialized programs, including those focused on music, retail, mobility, and social impact, with global reach extending to regions such as Africa, Asia, and Latin America. The firm prefers taking minority stakes, typically between six and ten percent, without seeking board representation or investor rights. Techstars has built a robust network of entrepreneurs, mentors, and corporate partners to foster innovation and growth within its portfolio, which includes over 1,000 companies with a significant collective market capitalization.

NVP Associates, LLC is a venture capital and private equity firm based in Palo Alto, California, specializing in a diverse range of investment stages and sectors. Established in 1961, the firm focuses on seed, startup, early, mid, and late-stage investments in both listed and unlisted companies, with particular emphasis on technology, healthcare, consumer products, and financial services. NVP Associates seeks to invest between $10 million and $150 million, depending on the stage and nature of the investment, often leading or co-investing with other firms. The firm has a global investment strategy, concentrating on markets in the Asia-Pacific region, the United States, India, Israel, and China. Its portfolio spans various industries, including medical devices, information technology, enterprise software, and digital health. NVP Associates aims to support companies with strong growth potential, leveraging its extensive network and operational expertise to foster development and achieve significant returns.

Transformation Capital is an independent management company that evolved from Leerink Transformation Partners LLC, which was established in 2016 by Todd Cozzens and Jared Kesselheim, MD. It received initial support from SVB Leerink Capital LLC, part of SVB Financial Group. In 2019, SVB acquired the Leerink businesses, leading to the formation of Transformation Capital, which now manages the investment portfolios of both Fund I and Fund II. Located in Boston, Massachusetts, Transformation Capital focuses on private equity growth investments primarily in healthcare technology systems and healthcare services across the United States, Canada, and the Americas. The firm is led by Kevin Brown, who previously served as CFO of Leerink Capital, and maintains a collaborative relationship with Leerink and SVB for operational support and strategic advantages.

The International Finance Corporation (IFC) is a member of The World Bank Group that focuses on fostering sustainable economic growth in developing countries through private sector investment. It provides a range of financial services, including loans, equity investments, quasi-equity products, and advisory services aimed at supporting startups and various stages of company development. IFC invests in sectors such as agribusiness, financial services, health, education, infrastructure, global manufacturing, oil and gas, telecommunications, and tourism, with a particular emphasis on projects that promote food security, digital finance, and affordable healthcare. The organization targets investments ranging from $1 million to $100 million, often seeking minority stakes but may also take a majority position in its portfolio companies. IFC aims to create jobs, generate tax revenues, and enhance corporate governance in emerging markets, thus contributing positively to local communities. Established in 1956 and headquartered in Washington, D.C., IFC operates globally with offices across various regions, focusing its efforts on financing projects that align with its mission of improving lives in developing countries.

Optum Ventures is a corporate venture capital firm founded in 2017 and located in Boston, Massachusetts, with an additional office in London. The firm focuses on investing in early-stage companies within the digital health and healthcare sectors that aim to disrupt the traditional healthcare landscape. By leveraging Optum's extensive data resources and industry insights, Optum Ventures provides its portfolio companies with significant advantages, helping them to connect and collaborate with key players in the healthcare ecosystem. The firm seeks to support transformative ideas that can enhance healthcare for everyone, fostering innovation and growth within the industry.

Polaris Partners is a venture capital firm founded in 1996 and headquartered in Boston, Massachusetts. With a focus on technology and healthcare sectors, Polaris invests in companies at all stages of development, from inception to profitable growth. The firm has a history of partnering with experienced entrepreneurs and innovators, aiming to enhance the way people live and work. In addition to its Boston headquarters, Polaris has offices in San Francisco and New York, and it actively targets investments in life sciences, biotechnology, and software industries across the United States and Europe. Over its more than two-decade history, Polaris Partners has established itself as a multibillion-dollar investment firm committed to fostering innovation and entrepreneurship.

Alumni Ventures Group, LLC is a venture capital firm founded in 2013 and based in Manchester, New Hampshire, with additional offices in North America. The firm specializes in seed, early-stage, and late-stage pre-IPO investments, focusing on companies that have an alumni connection and an institutional lead investor with relevant expertise. It offers high-quality, diversified venture portfolios to individual investors, particularly accredited alumni from top entrepreneurial schools, who previously lacked access to venture capital opportunities. Alumni Ventures Group invests between $0.01 million and $3 million in various sectors and geographies, without seeking board or observer seats. Additionally, the firm provides focused funds that enable any accredited investor to access a diverse venture portfolio, allowing for investment across different types, sectors, stages, and geographical locations.

8VC is a venture capital firm founded in 2015 and headquartered in San Francisco, California. The firm focuses on early-stage investments across various sectors, including healthcare, energy, consumer goods, logistics, biology, IT infrastructure, and government and defense. 8VC aims to catalyze industry transformation by promoting innovative platforms that can replace outdated technology infrastructures, thereby fostering greater innovation and global prosperity. Additionally, the firm manages co-investment funds that target software, telecommunications, media, technology, and 3D printing sectors. With a commitment to enabling significant advancements in these industries, 8VC positions itself as a key player in the venture capital landscape.

The AMA has a robust House of Delegates consisting of representation from every State and medical society, a solid base of physician members, a thriving advocacy influence, the most revered journals and resources in medicine, and respected practice tools.

Frist Cressey Ventures, LLC is a venture capital firm established in 2015 and based in Nashville, Tennessee. The firm specializes in investing in early and growth stage companies within the healthcare sector. It focuses on accelerating the development of high-potential healthcare enterprises by forming value-added partnerships. Frist Cressey Ventures seeks to invest in technology and service businesses that offer viable solutions aimed at enhancing the quality of care, improving system integration, and advancing patient outcomes and population health. The firm collaborates with entrepreneurs who share similar core values and are committed to transforming the healthcare landscape.

DNX Ventures is a private equity firm established in 2011 and based in San Mateo, California. The firm specializes in providing series A and B funding to early-stage B2B startups in the United States and Japan. DNX Ventures aims to facilitate growth for these startups by leveraging its extensive network of CXO connections within Fortune 500 companies, fostering partnerships that help validate product market fit and drive business development. To date, the firm has successfully created over 100 partnerships, aiding startups in their journey toward sustainable growth.

GIC Pte. Ltd. is a sovereign wealth fund established in 1981 to manage Singapore's foreign reserves. The firm aims to secure Singapore's financial future by investing across a diverse range of asset classes in both public and private markets. GIC's investment focus includes health care, financial and business services, natural resources, real estate, and fixed income. The fund also engages in alternative markets such as foreign exchange, commodities, and money markets. GIC provides seed capital via venture capital funds and invests in start-ups, growth companies, and pre- and post-listed entities, with a particular interest in the technology sector in China. The firm operates through its subsidiaries, including GIC Asset Management, GIC Real Estate, and GIC Special Investments, and maintains a global presence with offices in key financial centers worldwide.

Andreessen Horowitz LLC, founded in 2009 by Marc Andreessen and Ben Horowitz, is a venture capital firm based in Menlo Park, California. The firm specializes in investing across various stages of company development, from seed and early-stage to growth and late-stage ventures. It primarily targets the technology sector, with a strong emphasis on software, cloud computing, and Internet infrastructure. The firm also explores opportunities in consumer and business Internet applications, mobile software, and data storage, as well as at the intersection of computer science and life sciences, particularly in areas like digital therapeutics and computational medicine. Andreessen Horowitz is known for its significant financial backing, with investments typically ranging from $50,000 to $50 million. The firm has established multiple funds, including early-stage funds that focus on a variety of sectors, while explicitly avoiding investments in clean energy, transportation, and certain life sciences domains.

South Suez Capital is a private equity fund of funds manager based in Mauritius, specializing in investments across Africa. Established in 2009, the firm caters to institutional investors, endowments, and high-net-worth individuals, offering them exclusive access to a range of primary, secondary, and direct private market investments. By leveraging a well-established local network, South Suez Capital enables investors to build diversified portfolios focused on the African market. The firm's investment strategy includes targeting commitments to African private equity funds, along with direct investments in operating companies as opportunities arise. Additionally, South Suez Capital maintains a commitment to environmental, social, and governance (ESG) principles in its investment approach.

Memorial Hermann Hospital is a nonprofit health system based in Houston, Texas, founded in 1907 by Rev. Dennis Pevoto. It operates a comprehensive network that includes hospitals, inpatient rehabilitation facilities, specialty centers, diagnostic labs, imaging centers, and surgery centers. The health system also provides physical and occupational therapy services. In addition to its clinical offerings, Memorial Hermann facilitates an online platform for patients to pay bills and register for classes and events. The organization is supported by the Memorial Hermann Foundation, established in 1969, which aims to enhance community healthcare through financial support and various specialty programs. Memorial Hermann Hospital is dedicated to providing financial assistance and international services to its patients, reflecting its commitment to accessible healthcare for the greater Houston community.

The Patient-Centered Outcomes Research Institute (PCORI) is a nonprofit organization established by Congress to conduct research that informs patients and healthcare providers about the best available evidence for making healthcare decisions. Its primary aim is to enhance patients' understanding of prevention, treatment, and care options, as well as the scientific evidence that underpins these choices. By focusing on patient-centered research, PCORI seeks to empower individuals to engage more effectively in their healthcare processes, ultimately improving outcomes and quality of care.

Goldman Sachs is a global investment banking, securities, and investment management firm headquartered in New York City. Established in 1869, it provides a wide range of financial services to corporations, financial institutions, governments, and high-net-worth individuals. The firm operates through several segments, including Investment Banking, which offers financial advisory services related to mergers and acquisitions, and underwriting services for public and private offerings. Its Institutional Client Services segment facilitates client transactions across various asset classes and provides services like securities lending. The Investing & Lending segment focuses on long-term loans and investments in debt and equity securities, while the Investment Management segment offers portfolio management and wealth advisory services. Additionally, Goldman Sachs engages in private equity investments across multiple sectors and geographies, reinforcing its position as a leading investor in both public and private markets.

Great Oaks Venture Capital is a New York-based micro venture capital firm established in 2003, focusing on early-stage investments in consumer goods, technology, and healthcare sectors. The firm primarily targets seed and Series A funding rounds, supporting innovative startups that demonstrate growth potential. Great Oaks has built a diverse portfolio that includes well-known companies such as Acorns, Allbirds, and Flatiron Health, among others. By concentrating on early investments, Great Oaks aims to foster the development of emerging businesses and contribute to their long-term success.

Tencent Holdings Limited, founded in 1998 and headquartered in Shenzhen, is a leading internet service provider that offers a diverse range of value-added services and online advertising solutions. The company operates through several segments, including Value-Added Services (VAS), FinTech and Business Services, and Online Advertising. Tencent is well-known for its popular communication and social platforms, such as WeChat and QQ, which facilitate user connectivity and provide various digital content and lifestyle services. In addition to social networking, Tencent engages in online gaming, cloud services, and the production and distribution of films and television programs. The company's extensive portfolio also includes software development, information technology services, and online entertainment. Tencent's strategic focus is on delivering comprehensive online services that cater to the diverse needs of internet users, solidifying its position as a significant player in the global digital landscape.

Health Velocity Capital is a San Francisco-based private equity firm established in 2016, focusing on growth-stage investments in healthcare software and services companies throughout the United States. The firm aims to serve as a preferred innovation partner for entrepreneurs and investors, collaborating to enhance the quality, affordability, and sustainability of healthcare systems. By targeting companies that align with these goals, Health Velocity Capital seeks to drive advancements in the healthcare sector, ultimately benefiting both consumers and providers.

Bessemer Venture Partners is a $4 billion venture capital firm founded in 1911 and based in California, specializing in investments across consumer, enterprise, and healthcare sectors globally, from seed stage to growth. The firm supports founders by providing guidance and resources, starting with seed and Series A investments and maintaining involvement throughout the development of their companies. Bessemer has a diverse portfolio, having funded early-stage companies such as Pinterest, Blue Apron, Skype, and Twitch, and has played a role in the successful initial public offerings of 117 companies, including Twilio, Yelp, and LinkedIn. The firm also operates several specialized funds targeting various sectors, including information technology, software, and digital health, with a presence in key markets such as India and Israel.

SOSV is a global venture capital firm founded in 1995 and headquartered in Princeton, New Jersey. Specializing in seed-to-growth stage investments, SOSV operates multiple accelerator programs worldwide, including HAX for hardware, IndieBio and RebelBio for life sciences, Chinaccelerator and MOX for cross-border internet ventures, Food-X for innovative food solutions, and dlab for blockchain technology. The firm focuses on investments in revolutionary deep technologies aimed at improving human and planetary health, as well as cross-border markets, particularly in Asia. SOSV invests in approximately 150 startups annually, providing support through its resources to accelerate product development and scaling. Over its two-decade history, SOSV has established a strong reputation, consistently ranking among the top venture capital firms globally.

Elevar Equity, LLC is a private equity and venture capital firm that focuses on early-stage and growth equity investments in emerging markets. Established in 2006 and headquartered in Seattle, Washington, with additional offices in San Francisco, Bangalore, Mauritius, Bogota, and Mexico City, Elevar Equity targets entrepreneurs developing microfinance institutions and firms in sectors such as financial services, education, agriculture, healthcare, and housing. The firm emphasizes investments in Southeast Asia and Latin America, particularly in India, Peru, Brazil, Indonesia, and the Philippines, as well as Central America and Mexico. Elevar's investment strategy aims to support transformative ventures that provide essential products and services to low-income communities, impacting over 25 million underserved customers. The firm takes both minority and majority stakes in its portfolio companies, demonstrating a commitment to long-term growth and scalability. Through its investments, Elevar has catalyzed significant capital into numerous successful enterprises, contributing to the democratization of access to vital resources in targeted regions.

Foresight Group is an independent alternative asset manager based in London, United Kingdom, with over 30 years of experience in infrastructure and private equity investment. The firm specializes in environmental and solar infrastructure, managing more than £2.2 billion in assets on behalf of a diverse range of clients, including private individuals, family offices, pension funds, and institutional investors. Foresight offers various investment products, such as Listed Vehicles, Limited Partnerships, Venture Capital Trusts, and Enterprise Investment Schemes. Its investment strategy focuses on growth-stage companies across multiple sectors, including renewable energy, technology, healthcare, and advanced manufacturing, with a commitment to sustainable economic and social development. Foresight operates internationally, with offices located in the UK, USA, Italy, and Australia, and aims to generate long-term capital appreciation and increasing dividends for its investors.

.406 Ventures, LLC is a Boston-based venture capital firm founded in 2005 that specializes in early-stage investments, particularly in the information technology sector. The firm focuses on innovative companies in areas such as IT security and infrastructure, digital health, cloud technology, financial technology, and next-generation software. .406 Ventures typically invests between $2 million and $5 million initially, with total investments ranging from $6 million to $10 million per company. The firm seeks to be the lead institutional investor and often acquires significant stakes, ranging from 20 percent to 80 percent. It aims to provide board representation and actively supports its portfolio companies with its extensive industry experience and networks. Additionally, .406 Ventures allocates capital for opportunistic investments in more mature companies where technological shifts present growth opportunities. The firm primarily targets companies located in the Northeast and Southeast regions of the United States.

General Atlantic Service Company, L.P. is a global growth equity firm that specializes in making significant minority investments in growth-oriented companies. Founded in 1980 and headquartered in New York, the firm operates additional offices across major global cities, including Beijing, London, and Singapore. General Atlantic focuses on various sectors, including computer software and services, technology, consumer, financial services, and healthcare. The firm emphasizes a collaborative approach, leveraging sector-specific expertise and a long-term investment horizon to support entrepreneurs and management teams in building exceptional businesses. With a team of over 100 investment professionals, General Atlantic is committed to driving growth and delivering strategic support to its portfolio companies worldwide.

Direct Relief is a non-profit, non-partisan organization that provides medical assistance to people around the world who have been affected by poverty, natural disasters, and civil unrest. Thanks to generous material and financial contributions from individuals, pharmaceutical companies, and medical equipment manufacturers, Direct Relief can work with healthcare professionals and organizations on the ground and equip them with the essential medical supplies and equipment that they need to help people recover from a disaster.

Novo Holdings, established in 1999, is the holding company of the Novo Group, primarily managing the investment assets of the Novo Nordisk Foundation. Based in Copenhagen, with additional offices in San Francisco and Boston, Novo Holdings focuses on two main investment categories: Life Science Investments, which encompasses funding life science companies at various stages of development, and Financial Investments, which entails managing a diversified portfolio of equity and fixed income securities. As a prominent life science investor, Novo Holdings aims to create long-term value while ensuring that the Foundation can distribute returns for scientific, social, and humanitarian purposes to enhance public health and welfare. The company has also developed initiatives such as Novo Seeds, which supports early-stage applied research in life sciences, and invests in later-stage life science companies through growth equity. Novo Holdings maintains a strategic influence over affiliated companies, aligning their operations with the values and objectives of the Novo Group.

Magnum Capital is a prominent private equity firm based in Madrid, Spain, specializing in investments in mid-to-upper middle market companies across Spain and Portugal. Established in 2006, the firm focuses exclusively on the Iberian Peninsula, targeting growth-stage businesses with substantial potential for value creation. Magnum Capital employs a rigorous due diligence process to assess investment opportunities before making decisions. The firm manages multiple funds and predominantly invests in various sectors, including commercial products, manufacturing, and healthcare devices, concentrating on companies with enterprise values ranging from EUR 100 million to EUR 800 million. As one of the largest private equity firms in the region, Magnum Capital plays a significant role in fostering the growth of Iberian companies.

5Y Capital is a private equity and venture capital firm based in Shanghai, China, specializing in seed, startup, early venture, and growth capital investments. Established in 1992, the firm focuses on a diverse range of sectors, including healthcare, technology, fintech, internet services, consumer services, media, and life sciences, among others. It aims to support entrepreneurs in building innovative companies, particularly in China and other emerging markets in Asia/Pacific. Managing approximately USD 5 billion in dual-currency funds, 5Y Capital attracts investments from global sources, including sovereign wealth funds and family offices. The firm typically makes initial investments exceeding USD 500,000 per portfolio company. 5Y Capital operates under the Morningside Group, which is committed to socially responsible investing, particularly in educational opportunities and scientific research.

LifePoint Health, founded in 1999, operates a network of community hospitals, regional health systems, physician practices, and outpatient centers primarily in non-urban markets across the United States. The organization is dedicated to providing quality healthcare close to home, emphasizing the importance of strong healthcare systems for fostering healthy communities. With over 15 years of experience, LifePoint Health focuses on understanding and addressing the unique healthcare needs of each community it serves. The company invests in advanced technology, facility enhancements, and the recruitment and development of healthcare professionals to ensure high standards of care and service. By equipping its facilities and providers with essential resources, LifePoint Health aims to deliver excellent healthcare and thrive in the evolving healthcare landscape.

Acadia Healthcare Company, Inc. is dedicated to developing and operating a comprehensive network of behavioral health facilities in the United States, the United Kingdom, and Puerto Rico. Founded in 2005 and headquartered in Franklin, Tennessee, Acadia focuses on providing a range of services, including inpatient psychiatric hospitals, residential treatment centers, outpatient clinics, and therapeutic programs for children. The company specializes in treating individuals facing mental health challenges, substance abuse disorders, and co-occurring conditions. Its facilities include acute inpatient care for those at risk of harming themselves or others, as well as long-term services for individuals dealing with mental illness or addiction. Acadia's revenue is primarily derived from Medicaid and commercial payors in the U.S., while in the U.K., the majority comes from the National Health Service. Acadia aims to deliver high-quality care in a supportive environment, emphasizing collaboration and a commitment to patient well-being.

500 Global, formerly known as 500 Startups, is a venture capital firm and incubator based in Mountain View, California, founded in 2010. The firm specializes in seed investments, primarily focusing on early-stage technology and financial services startups across various sectors, including biotech, e-commerce, fintech, and digital healthcare. 500 Global operates a four-month accelerator program, where it typically invests between $0.05 million and $1 million for a 5 to 10 percent equity stake in companies with at least $100,000 in monthly revenue. The firm targets a global market, with particular emphasis on regions such as the Middle East, Asia, Europe, and Latin America. Since its inception, it has invested in over 2,200 startups and supports the growth of innovation ecosystems through educational programs and partnerships. 500 Global also prioritizes investments in companies led by minority founders, reflecting its commitment to diverse entrepreneurial leadership.

RRE Ventures, established in 1994 and based in New York, is a private equity firm specializing in venture capital investments in the technology and financial services sectors. With over $1.5 billion in assets, RRE focuses on seed, Series A, and Series B funding for rapidly growing companies in software, internet, communications, and related industries. The firm prioritizes backing entrepreneurs and management teams with the vision and expertise necessary to build market-leading companies. RRE’s team combines management, operational, and investment experience, leveraging a robust network of relationships to support the growth of its portfolio companies. Through its targeted investments, RRE Ventures aims to foster innovation and drive success in the technology landscape.

Maddie's Fund is a non-profit organization established in 1994 by Dave Duffield and Cheryl Duffield. The foundation, named after their beloved Miniature Schnauzer, Maddie, has been endowed with over $300 million and has awarded more than $247.3 million in grants aimed at enhancing community lifesaving efforts, shelter management, shelter medicine education, and foster care across the United States. Maddie's Fund is dedicated to the mission of creating a no-kill nation, ensuring that every dog and cat has the opportunity for a healthy home or habitat. Through its initiatives, the foundation seeks to improve the welfare of domestic animals, particularly dogs, and to promote effective strategies for animal sheltering and care.

AstraZeneca is a global biopharmaceutical company that specializes in the discovery, development, manufacturing, and marketing of prescription medicines. Founded in 1999 through a merger between Astra of Sweden and Zeneca Group of the United Kingdom, the company focuses on a range of therapeutic areas including oncology, cardiovascular, renal, metabolic diseases, respiratory, autoimmunity, infection, neuroscience, and gastroenterology. AstraZeneca's extensive portfolio includes well-known brands such as Imfinzi, Lynparza, and Tagrisso, among others. The company operates internationally, with a significant portion of its sales coming from markets outside the United States, although the U.S. remains a key market. AstraZeneca Pharma India Limited, a subsidiary based in Bengaluru, manufactures and markets pharmaceutical products primarily in India, emphasizing areas like cardiovascular health, oncology, and respiratory diseases. Through continuous research and innovation, AstraZeneca aims to improve patient outcomes and enhance the quality of life for individuals worldwide.

Adams Street Partners is a global private market investment management firm that specializes in providing investment management capabilities in venture capital and private equity partnerships to institutional investors. Established in 2001 by a team from Brinson Partners' Private Equity Group, the firm is independent and employee-owned, with over 45 years of experience in navigating the complexities of private markets. Adams Street maintains a diversified investment portfolio, primarily focusing on private equity, with a smaller allocation to private debt. The firm is recognized for its disciplined investment approach, commitment to quality, and strong performance. Its collaborative team leverages extensive global resources to deliver world-class investment performance and exemplary client service, ensuring the confidence of its investors in a challenging investment landscape.

Questa Capital Management is a healthcare venture growth equity firm based in the United States, established in 2016. The firm focuses on early-stage investments in healthcare and biotech companies throughout North America. Questa Capital seeks to identify disruptive business models that enhance quality of life and improve care efficiency. By partnering with skilled management teams, the firm aims to build innovative market leaders in the healthcare sector. Its mission is to deliver exceptional returns for both investors and management teams.

Kain PC is a private equity fund managed by Kain Capital, established in 2014 and based in New York. The fund focuses on early-stage investments, primarily targeting the healthcare sector, including clinics, outpatient services, and managed care, as well as sectors related to elder and disabled care. Kain Capital employs a collaborative investment approach to foster long-term value and aims to achieve improved outcomes through active partnerships with its business associates.

Partech is a global investment firm established in 1982, with offices in San Francisco, Paris, Berlin, and Dakar. The firm focuses on providing capital and strategic support to entrepreneurs at various stages, including seed, venture, and growth phases. With an investment capacity exceeding $1.5 billion, Partech's investments typically range from $200,000 to $50 million across a diverse array of sectors such as software, fintech, digital brands, and deep tech. The firm manages several funds, including Partech Africa II, which targets African startups in technology and consumer services, and Partech Growth II, aimed at growth-stage companies in Europe. Partech's portfolio has seen significant success, with over 20 companies achieving initial public offerings and more than 50 strategic exits valued above $100 million.

Mayo Clinic is a not-for-profit medical group practice established in 1864, with its headquarters in Rochester, Minnesota. The organization operates medical care facilities across several states, including Minnesota, Florida, and Arizona, offering a wide range of services in specialties such as diabetes, cancer, neurology, and cardiology. In addition to patient care, Mayo Clinic is deeply involved in medical education, providing various degree and certificate programs, and conducting extensive research to advance healthcare through the development of diagnostic tools, medications, and treatment protocols. The institution emphasizes collaboration between physicians and scientists to foster innovation and improve patient outcomes. As a foundation, its operations are supported by the Mayo Foundation for Medical Education and Research, reinforcing its commitment to enhancing healthcare and education in the medical field.

The CU Healthcare Innovation Fund is located on the University of Colorado Anschutz Medical Campus in Aurora, Colorado. The fund invests in companies that have developed meaningful partnerships with the institutions on the campus. The $50 million fund invests across digital health, therapeutics and devices.

BlueMountain Capital Management, founded in 2003 and headquartered in New York, is a diversified alternative asset management firm with an additional office in London. The firm specializes in providing debt services primarily to sectors such as financial services, energy, healthcare, and technology in the United States and Europe. It manages pooled investment vehicles as well as institutional accounts, typically structured as single-investor limited partnerships or foreign entities. BlueMountain employs a combination of fundamental and quantitative analysis to develop client-focused portfolios that invest across public equity, fixed income, and alternative investment markets worldwide. Its alternative investments encompass a wide range of strategies, including long/short credit, long/short equity, distressed situations, and various structured credit products.

Fresenius Medical Care is a leading provider of healthcare services and products for individuals with chronic kidney disease and related conditions. The company operates a vast network of 2,716 dialysis clinics across North America, Europe, Latin America, Asia-Pacific, and Africa. In addition to dialysis facilities, it offers outpatient cardiac and vascular labs, urgent care centers, specialty pharmacy, and laboratory services. Fresenius Medical Care manufactures and distributes a comprehensive range of dialysis equipment, disposable products, and renal pharmaceuticals. Founded in 1996 and headquartered in Waltham, Massachusetts, the company is committed to improving the quality of care for patients with renal conditions. It also engages in initiatives to support kidney health, demonstrating its dedication to the well-being of its patient population.